New Zealand markets open in 6 hours 25 minutes

Candel Therapeutics, Inc. (CADL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.50-1.20 (-9.45%)
At close: 04:00PM EDT
11.60 +0.10 (+0.87%)
After hours: 07:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 342.06M
Enterprise value 337.44M
Trailing P/E 63.17
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)436.42
Price/book (mrq)57.21
Enterprise value/revenue 821.98
Enterprise value/EBITDA -0.01

Trading information

Stock price history

Beta (5Y monthly) -0.93
52-week change 3580.47%
S&P500 52-week change 326.49%
52-week high 314.30
52-week low 30.66
50-day moving average 35.53
200-day moving average 32.26

Share statistics

Avg vol (3-month) 35.49M
Avg vol (10-day) 31.01M
Shares outstanding 529.74M
Implied shares outstanding 629.74M
Float 818.22M
% held by insiders 133.19%
% held by institutions 115.10%
Shares short (30 Apr 2024) 41.05M
Short ratio (30 Apr 2024) 40.07
Short % of float (30 Apr 2024) 45.37%
Short % of shares outstanding (30 Apr 2024) 43.59%
Shares short (prior month 28 Mar 2024) 4160.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-40.36%
Return on equity (ttm)-125.50%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -37.43M
Net income avi to common (ttm)-37.94M
Diluted EPS (ttm)-1.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)35.41M
Total cash per share (mrq)1.21
Total debt (mrq)22.76M
Total debt/equity (mrq)178.60%
Current ratio (mrq)2.59
Book value per share (mrq)0.44

Cash flow statement

Operating cash flow (ttm)-34.24M
Levered free cash flow (ttm)-21.57M